- High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
-
Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2373986
- Korean J Ophthalmol.
- 2016 Aug;30(4):265-271.
- doi: 10.3341/kjo.2016.30.4.265
PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent... -
- CITED
-
- Close
- SHARE
-
- Close
